Status:
RECRUITING
CirrhosisRx CDS System
Lead Sponsor:
University of California, San Francisco
Conditions:
Cirrhosis
Decision Support Systems, Clinical
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures...
Detailed Description
Each year, there over 200,000 hospitalizations for cirrhosis in the United States. Over one-third of these patients are readmitted within 30 days, and up to 10% will die in the hospital. Despite natio...
Eligibility Criteria
Inclusion
- All adult (age ≥ 18 years) patients who have a previous history of cirrhosis identified based on 1+ chronic liver disease and 1+ cirrhosis (or its complications) International Classification of Diseases, Revision 10 diagnosis codes admitted at our institution.
Exclusion
- Children (age \< 18 years)
- patients who do not meet the cirrhosis definition criteria as noted above
- ambulatory patients
Key Trial Info
Start Date :
January 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
2106 Patients enrolled
Trial Details
Trial ID
NCT05967273
Start Date
January 14 2025
End Date
June 1 2027
Last Update
March 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco Medical Center
San Francisco, California, United States, 94143